Shannon Kelley sold $431K of Madrigal Pharmaceuticals stock
By AlphaYouPublished Form 4
Kelley Shannon T
Reporting filer
Shannon Kelley reported selling 1,077 shares of Madrigal Pharmaceuticals, Inc. for about $431K ($400.00 a share on average). Form 4 filed Nov 6, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 6, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Kelley Shannon T | 2026-11-06 | S | Sale | 1077 | 400 | 10,397 | 0 days | Filed terms
|
Common Stock
- Owner
- Kelley Shannon T
- Date
- 2026-11-06
- Code
- S
- Action
- Sale
- Quantity
- 1077
- Price
- 400
- Following holdings
- 10,397
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1077
- transaction Price Per Share: 400
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 10397
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Kelley Shannon T: General Counsel.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This sale was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.